Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc., which is headquartered in Vancouver, Canada.

Achieve Life Sciences, Inc.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Achieve Life Sciences (ACHV) and Jade Biosciences (J...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ACHV	$7.54	-3.70%	1.42M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ACHV	$7.54	-3.7%	1.42M
3
4
5
6

ACHV

Get Achieve Life Sciences, Inc. Data in Excel

Get Achieve Life Sciences, Inc. Data in Excel